Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov
Condition: Gastrointestinal Cancer
Study Type: Interventional
Study Start Date: 02/06/2019
Study Completion Date: 07/2021
This is a Phase 1/1b, open-label, dose-escalation, and dose-expansion study to evaluate the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and clinical activity of AB928 in combination with mFOLFOX in participants with advanced metastatic gastroesophageal Cancer (GEC) or colorectal cancer (CRC).